FDA Approved: * September 15, 2006 Pharm Company: *MAYNE PHARMA USA Category:Cancer
Epirubicin is an anthracycline drug used for chemotherapy. It can be used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is marketed by Pfizer under the trade name Ellence in the US and Pharmorubicin or Epirubicin Ebewe elsewhere.
Similarly to other anthracyclines, epirubicin acts by intercalating DNA strands.
Intercalation results in complex formation which inhibits DNA and RNA synthesis. It also triggers DNA cleavage by...
* May have multiple approval dates, manufacturers, or labelers.